Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
Clinical trial NCT02209376 · TERMINATED
Trial details
- NCT number
- NCT02209376
- Sponsor
- University of Pennsylvania
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-18
- Primary completion
- 2018-04-04
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.